IL4R and atopic eczema: Individuals with high IgE at baseline in several diseases show clinical benefit with anti‐IL‐4Rα (dupilumab) treatment, for example, in alopecia areata, allergic asthma, and atopic dermatitis.163, 164, 165, 166